Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Lídia Ordacgi, Mauro V Mendlowicz & Leonardo F Fontenelle. (2009) Management of obsessive-compulsive disorder with fluvoxamine extended release. Neuropsychiatric Disease and Treatment 5, pages 301-308.
Read now
Read now
Leonardo F. Fontenelle, Mauro V. Mendlowicz & Marcio Versiani. (2009) Volitional disorders: A proposal for DSM-V. The World Journal of Biological Psychiatry 10:4-3, pages 1016-1029.
Read now
Read now
Marco Grados & Holly C Wilcox. (2007) Genetics of obsessive–compulsive disorder: a research update. Expert Review of Neurotherapeutics 7:8, pages 967-980.
Read now
Read now
Articles from other publishers (20)
Daniel R Schaffer, Hamid R Okhravi & Serina A Neumann. (2021) Low-Frequency Transcranial Magnetic Stimulation (LF-TMS) in Treating Depression in Patients With Impaired Cognitive Functioning. Archives of Clinical Neuropsychology 36:5, pages 801-814.
Crossref
Crossref
Joshua PepperLudvic Zrinzo & Marwan Hariz. (2020) Anterior capsulotomy for obsessive-compulsive disorder: a review of old and new literature. Journal of Neurosurgery 133:5, pages 1595-1604.
Crossref
Crossref
Swarup Mitra & Abel Bult-Ito. (2018) Attenuation of compulsive-like behavior by fluvoxamine in a non-induced mouse model of obsessive–compulsive disorder. Behavioural Pharmacology 29:4, pages 299-305.
Crossref
Crossref
Ulku Akyol Ardic, Eyup Sabri Ercan, Ayse Kutlu, Deniz Yuce, Melis Ipci & Sevim Berrin Inci. (2016) Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive–Compulsive Disorder in Childhood. Child Psychiatry & Human Development 48:5, pages 699-704.
Crossref
Crossref
Daniel Rutrick, Dan J. Stein, Ganesan Subramanian, Brian Smith, Maurizio Fava, Gregor Hasler, Jang-Ho Cha, Fabrizio Gasparini, Toni Donchev, Magdalena Ocwieja, Donald Johns & Baltazar Gomez-Mancilla. (2017) Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study. Advances in Therapy 34:2, pages 524-541.
Crossref
Crossref
Ratana Saipanish, Thanita Hiranyatheb, Sudawan Jullagate & Manote Lotrakul. (2015) A study of diagnostic accuracy of the Florida Obsessive-Compulsive Inventory – Thai Version (FOCI-T). BMC Psychiatry 15:1.
Crossref
Crossref
Shaheen Lakhan & Karen Vieira. 2013. Functional Foods. Functional Foods
91
108
.
Juliana B Diniz & Leonardo F Fontenelle. (2013) Obsessive–compulsive disorder: how should we manage treatment nonadherence?. Neuropsychiatry 3:5, pages 451-453.
Crossref
Crossref
Ivan Skelin, Maraki Fikre-Merid & Mirko Diksic. (2012) Both acute and subchronic treatments with pindolol, a 5-HT1A and β1 and β2 adrenoceptor antagonist, elevate regional serotonin synthesis in the rat brain: An autoradiographic study. Neurochemistry International 61:8, pages 1417-1423.
Crossref
Crossref
Mehdi Sayyah, Mohammad Sayyah, Hatam Boostani, Seyyed Mohammad Ghaffari & Abedin Hoseini. (2012) EFFECTS OF ARIPIPRAZOLE AUGMENTATION IN TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER (A DOUBLE BLIND CLINICAL TRIAL). Depression and Anxiety 29:10, pages 850-854.
Crossref
Crossref
Christal L. Badour, Stephanie Bown, Thomas G. Adams, Liviu Bunaciu & Matthew T. Feldner. (2012) Specificity of fear and disgust experienced during traumatic interpersonal victimization in predicting posttraumatic stress and contamination-based obsessive–compulsive symptoms. Journal of Anxiety Disorders 26:5, pages 590-598.
Crossref
Crossref
Leonardo F. Fontenelle, Ashleigh Lin, Christos Pantelis, Stephen J. Wood, Barnaby Nelson & Alison R. Yung. (2012) Markers of vulnerability to obsessive-compulsive disorder in an ultra-high risk sample of patients who developed psychosis. Early Intervention in Psychiatry 6:2, pages 201-206.
Crossref
Crossref
Leonardo F. Fontenelle, Sanne Oostermeijer, Ben J. Harrison, Christos Pantelis & Murat Yücel. (2011) Obsessive-Compulsive Disorder, Impulse Control Disorders and Drug Addiction. Drugs 71:7, pages 827-840.
Crossref
Crossref
Yavuz Selvi, Abdullah Atli, Adem Aydin, Lutfullah Besiroglu, Pinar Ozdemir & Osman Ozdemir. (2011) The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor‐refractory obsessive‐compulsive disorder: a single‐blind, randomised study. Human Psychopharmacology: Clinical and Experimental 26:1, pages 51-57.
Crossref
Crossref
Ö. Uzun. (2008) Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report. Journal of Psychopharmacology 24:3, pages 425-427.
Crossref
Crossref
Victor Fossaluza, Juliana Belo Diniz, Basilio de Bragança Pereira, Eurípedes Constantino Miguel & Carlos Alberto de Bragança Pereira. (2009) Sequential Allocation to Balance Prognostic Factors in a Psychiatric Clinical Trial. Clinics 64:6, pages 511-518.
Crossref
Crossref
Shaheen E Lakhan & Karen F Vieira. (2008) Nutritional therapies for mental disorders. Nutrition Journal 7:1.
Crossref
Crossref
Anna I. Guerdjikova, Susan L. McElroy, Renu Kotwal, Jeffrey A. Welge, Erik Nelson, Katie Lake, David D' Alessio, Paul E. KeckJrJr & James I. Hudson. (2007) High‐dose escitalopram in the treatment of binge‐eating disorder with obesity: a placebo‐controlled monotherapy trial. Human Psychopharmacology: Clinical and Experimental 23:1, pages 1-11.
Crossref
Crossref
Felipe Filardi da Rocha & Humberto Correa. (2007) Successful augmentation with aripiprazole in clomipramine-refractory obsessive–compulsive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:7, pages 1550-1551.
Crossref
Crossref
Ygor Arzeno Ferrão, Juliana Belo Diniz, Antônio Carlos Lopes, Roseli Gedanke Shavitt, Benjamin Greenberg & Euripedes Miguel. (2007) Resistência e refratariedade no transtorno obsessivo-compulsivo. Revista Brasileira de Psiquiatria 29:suppl 2, pages S66-S76.
Crossref
Crossref